Aurinia says Teva generic voclosporin may launch after 2036
Aurinia Pharmaceuticals says Teva may launch a generic version of voclosporin in the U.S. no earlier than December 7, 2036, while patent litigation continues in New Jersey.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.